Why the Shift from Pharma Glass to Plastic?
Pharmaceutical packaging has undergone a shift in market preference, with manufacturers preferring plastic to pharma glass. This is the case primarily with the injectable devices segment. The change in preference has triggered a recent shift in product portfolio of certain renowned parenteral packaging supplier companies. This has been done to meet market demand.
A number of important tests were carried out to ascertain if it would be feasible to shift shifting from pharma glass to plastic.
The factors that influenced the shift to plastic include: -
One of the primary reasons that triggered the shift includes advancements in the drug formulation stage. This led to an increased drug complexity as well as quality challenges that arise due to the use of glass, which includes breakage, delamination , in addition to siliconization, among other factors. The problems that glass face have also proved to be a cause of concern for pharma players’ injectable drug’s packaging procurement. Why is it a problem? It can be attributed to the supply base, which is characterized by long term contracts.
Here are some of the main reasons why parenteral packaging is necessary:
Drugs are administered primarily through intravenous, intradermal or the intra ocular formats - called parenteral drugs. These drugs differ from conventional oral and extra dermal drug intake. Parenteral drugs help to cure diseases like cancer, rheumatoid arthritis and diabetes and other diseases. Therefore, in these cases, injectable is an effective method of administration.
Also, parenteral packaging is among the fastest growing pharmaceutical packaging formats. Therefore, the shift to plastic does not come as a big surprise. In fact, Industrial Agitators for the pharmaceutical industry have helped the sector boom. These industrial agitators are used for a number of mixing operations.
Pharmaceutical packaging has undergone a shift in market preference, with manufacturers preferring plastic to pharma glass. This is the case primarily with the injectable devices segment. The change in preference has triggered a recent shift in product portfolio of certain renowned parenteral packaging supplier companies. This has been done to meet market demand.
A number of important tests were carried out to ascertain if it would be feasible to shift shifting from pharma glass to plastic.
The factors that influenced the shift to plastic include: -
One of the primary reasons that triggered the shift includes advancements in the drug formulation stage. This led to an increased drug complexity as well as quality challenges that arise due to the use of glass, which includes breakage, delamination , in addition to siliconization, among other factors. The problems that glass face have also proved to be a cause of concern for pharma players’ injectable drug’s packaging procurement. Why is it a problem? It can be attributed to the supply base, which is characterized by long term contracts.
Here are some of the main reasons why parenteral packaging is necessary:
Drugs are administered primarily through intravenous, intradermal or the intra ocular formats - called parenteral drugs. These drugs differ from conventional oral and extra dermal drug intake. Parenteral drugs help to cure diseases like cancer, rheumatoid arthritis and diabetes and other diseases. Therefore, in these cases, injectable is an effective method of administration.
Also, parenteral packaging is among the fastest growing pharmaceutical packaging formats. Therefore, the shift to plastic does not come as a big surprise. In fact, Industrial Agitators for the pharmaceutical industry have helped the sector boom. These industrial agitators are used for a number of mixing operations.
No comments:
Post a Comment